Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- spasms
- head nodding
- neurodevelopmental delay or regression
Outros fatores diagnósticos
- onset age 3-12 months
- perinatal complication
- abnormal eye movements
- microcephaly
- ash-leaf macules
- motor system abnormalities
Fatores de risco
- brain malformation
- neurocutaneous abnormalities
- prenatal or perinatal vascular event
- intrauterine or perinatal infections
- inherited metabolic disorder
- genetic disorders
- family history
- neonatal sinovenous thrombosis
- postnatal brain injury
- brain tumors
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- sleep electroencephalogram (EEG)
- complete blood count
- blood chemistries
- plasma glucose
- serum calcium
- serum magnesium
- liver function tests
- ammonia
- blood gas
- plasma lactate/pyruvate
- plasma amino acids
- urine organic acids
- acylcarnitines (blood spot)
- biotinidase
- urine alpha-amino adipic semialdehyde dehydrogenase (AASA)
- urine and plasma creatine and guanidinoacetate
- next-generation sequencing: gene panel/whole-exome sequencing/whole-genome sequencing
- microarray comparative genome hybridization (CGH)
- brain MRI
Investigações a serem consideradas
- cerebrospinal fluid (CSF) exam
- thyroid function tests (free thyroxine [FT4], thyroid-stimulating hormone [TSH])
- plasma transferrin glycoforms
- very long-chain fatty acids
- serum copper, ceruloplasmin
- urine sulfocysteine
- CT brain
- cytomegalovirus (CMV) culture, polymerase chain reaction (PCR), or serology
- toxoplasmosis serology
- echocardiogram
- renal ultrasound
- ophthalmology exam
Algoritmo de tratamento
all patients
Colaboradores
Autores
Robert Robinson, MA, MBBS, FRCP, PhD
Consultant Paediatric Neurologist
Great Ormond Street Hospital
London
UK
Declarações
RR declares that he has no competing interests.
Sarah Buts, MD
Clinical Fellow in Paediatric Neurology
Great Ormond Street Hospital
London
UK
Declarações
SB declares that she has no competing interests.
Agradecimentos
Dr Robert Robinson and Dr Sarah Buts would like to gratefully acknowledge Dr Katharina Vezyroglou, Dr Marjorie Illingworth, Dr Pradnya Gadgil, Dr Teesta Soman, and Dr Shelly Weiss, previous contributors to this topic.
Declarações
KV, MI, PG, TS, and SW declare that they have no competing interests.
Revisores
Gregory L. Holmes, MD
Section Chief of Neurology
Dartmouth-Hitchcock Medical Center
Lebanon
NH
Declarações
GLH declares that he has no competing interests.
Maria Roberta Cilio, MD, PhD
Attending Pediatric Neurologist
Division of Neurology
Bambino Gesu Children's Hospital
Rome
Italy
Declarações
MRC declares that she has no competing interests.
Lionel Carmant, MD
Professor of Neurology
Department of Pediatrics
University of Montreal
Director of Epilepsy Clinic and Research Group
Saint Justine Hospital
Montreal
QC
Canada
Declarações
LC declares that he has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Hancock EC, Osborne JP, Edwards SW. Treatment of infantile spasms. Cochrane Database Syst Rev. 2013 Jun 5;(6):CD001770.Texto completo Resumo
Go CY, Mackay MT, Weiss SK, et al; Child Neurology Society; American Academy of Neurology. Evidence-based guideline update: medical treatment of infantile spasms. Neurology. 2012 Jun 12;78(24):1974-80.Texto completo Resumo
Lux AL, Edwards SW, Hancock E, et al. The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial. Lancet Neurol. 2005 Nov;4(11):712-7. Resumo
National Institute for Health and Care Excellence. Epilepsies in children, young people and adults. Apr 2022 [internet publication].Texto completo
O'Callaghan FJ, Edwards SW, Alber FD, et al. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial. Lancet Neurol. 2017 Jan;16(1):33-42.Texto completo Resumo
Willmore LJ, Abelson MB, Ben-Menachem E, et al. Vigabatrin: 2008 update. Epilepsia. 2009 Feb;50(2):163-73. Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

Differentials
- Dravet syndrome
- Benign familial infantile seizures
- Benign sleep myoclonus
Mais DifferentialsGuidelines
- Evidence-based guideline update: medical treatment of infantile spasms
- Infantile spasms: a US consensus report
Mais GuidelinesFolhetos informativos para os pacientes
Epilepsy: questions to ask your doctor
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal